EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

N‐Lactoyl Amino Acids: Emerging Biomarkers in Metabolism and Disease

Khaled Naja iD, Laila Hedaya iD, Asma A Elashi iD, Manfredi Rizzo, Mohamed A Elrayess

Diabetes/Metabolism Research and Reviews · 2025-07 · 41 (5)

DOI: 10.1002/dmrr.70060 ↗

At a glance

Übersichtsarbeit in Diabetes/Metabolism Research and Reviews, published online on 2025-06-18. Written by Khaled Naja and 4 co-authors. Institution: Biomedical Research Center, QU Health, Qatar University, Doha, Qatar. Major MEDLINE topics: Biomarkers, Amino Acids, Metabolic Diseases. Cited 13 times so far (Crossref); 99 references. The full text is freely available in PubMed Central. Funded by: Qatar Research, Development and Innovation (QRDI) Council, Qatar National Research Fund.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

N‐lactoyl amino acids (Lac‐AA) form an emerging class of metabolites that have gained significant attention in recent years due to their ubiquitous presence in different biological systems and potential roles in various biochemical processes. This narrative review aims to provide a comprehensive overview of the current understanding of Lac‐AA, emphasising their biosynthesis, physiological roles, and potential implications in various diseases. We discuss the discovery of Lac‐AA as signalling molecules, and their involvement in exercise‐induced appetite suppression, energy metabolism, and other pathways. This review explores the complex relationship between Lac‐AA and various pathological conditions, including mitochondrial disorders, type 2 diabetes, phenylketonuria, cancer, and rosacea. We also examine the interplay between Lac‐AA and the gut microbiota, as well as their association with metformin treatment. Furthermore, we address the ongoing debate regarding whether Lac‐AA are merely reflections of lactate and amino acid levels or independent signalling molecules. This review synthesises the latest research findings, highlights the significance of Lac‐AA in metabolic research, and identifies promising avenues for future investigation in this rapidly evolving field.

Subjects

MeSH terms (MEDLINE)

BiomarkersAmino AcidsMetabolic DiseasesHumansAnimalsEnergy MetabolismDiabetes Mellitus, Type 2Gastrointestinal Microbiome

Author keywords

Lac‐PheN‐lactoyl amino acidslactatemetabolite

Substances

BiomarkersAmino Acids

Authors and institutions

  • Biomedical Research Center, QU Health, Qatar University, Doha, Qatar.
  • School of Medicine, Promise Department, University of Palermo, Palermo, Italy.
  • Department of Medicine, Ras Al Khaimah (RAK) Medical and Health Sciences University, Ras Al Khaimah, UAE.
  • College of Medicine, QU Health, Qatar University, Doha, Qatar.

ORCID profiles: Khaled Naja, Laila Hedaya, Asma A Elashi

Funding

  • Qatar Research, Development and Innovation (QRDI) Council
  • Qatar National Research Fund

Cite

APA

Naja, K., Hedaya, L., Elashi, A. A., Rizzo, M., & Elrayess, M. A. (2025). N‐Lactoyl Amino Acids: Emerging Biomarkers in Metabolism and Disease. Diabetes/Metabolism Research and Reviews, 41(5). https://doi.org/10.1002/dmrr.70060

Vancouver

Naja K, Hedaya L, Elashi AA, Rizzo M, Elrayess MA. N‐Lactoyl Amino Acids: Emerging Biomarkers in Metabolism and Disease. Diabetes/Metabolism Research and Reviews. 2025;41(5). doi:10.1002/dmrr.70060

BibTeX
@article{Naja2025,
  author = {Naja, Khaled and Hedaya, Laila and Elashi, Asma A and Rizzo, Manfredi and Elrayess, Mohamed A},
  title = {N‐Lactoyl Amino Acids: Emerging Biomarkers in Metabolism and Disease},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2025},
  volume = {41},
  number = {5},
  doi = {10.1002/dmrr.70060}
}
Start for free →